Member Info for aj242

exactly

Ffs, new influx of rampers are arriving, only to be disappointed when this goes back to sub 3p. Need that 002 news

excellent RNS there to soothe anyone that was nervous. Huge Huge upside

Apologies, thanks for clearing up

Disagree; the video dropped today and he says if the announcement happens by the time the video is up, they will share the link which they haven’t? Surely it’s something else?

I think its fair to say given the number of projects they are working on, we could see a reasonably exponential rise here similar to that GGP had last year. Very exciting times and glad this is a board of research, rather than nonsence ramping/deramping

Can we put some monopoly money bets on when NXP002 news will drop. I am going to say in March

Thanks Neutronic.

so much for a big week. Was meant to be a transformational year lol. Hopefully it lands this decade

Can anyone share the Fincapp note on AVCT this morning. I don't have access. Thanks

I think its quite obviously a good thing that we have a serious overseas II on board. Why on earth would they bother investing if they didn't see the upside. Next year will be absolutely transformation, probably by H1 I would be expecting well north of 50p.

If you have a 100k investor and you're busy on this forum you're either a big gambler or a liar.

Very much doubt he is selling, but will send him a message now, lets see if he replies

surprised no one has said "MM 1 CODE MESSAGE, RNS TOMORROW" lol

I am trying to be optimistic here, we have had a few good appointments that have been delivered as promised. In regards to the big deal, what do you guys think are the timelines. Still Q4?

As I have always said, excellent tech but the company is run poorly, hopefully now with this new team, we can see improvements but I do hope they come imminently rather than another 6 months away...

Senior pharmaceutical R&D executive and consultant with >30 years’ experience in big pharma & biotech. Successful international track record of driving projects and portfolios towards the market and leading different organisations through strategic change including leading a company to a successful exit. Passionate about bringing innovative products to patients thereby adding to company value. Broad leadership experience as a biotech CEO and executive, functional line leader and cross-functional project leader. Adept in leading small R&D company, including fundraising, strategy, portfolio, financing, IP, legal and business development aspects.

High expertise in small molecule R&D spanning discovery, early and late development, through to registration and commercialisation in respiratory / pulmonary and oncology therapy areas. Renowned for deep CMC expertise in inhaled therapies, including dry powder inhalers, metered dose inhalers and nebulisers for both innovator and generic products.

Good news we have a new CEO, this will still finish in the high 2s most likely. Blackwell said by the end of the year so not long to go, unless of course they miss another deadline lol

So that’s one 3.7m trade and another 3.9m trade. Nearly £10m

Another massive trade just went through?!

Genuinely think, after 8 months holding, tomorrow might be the day